Table 4.
EQ-5D health utility |
Visual analogue scale |
|||
---|---|---|---|---|
Differences observed-predicted* Mean (SD) |
p Value† | Differences observed-predicted‡ Mean (SD) |
p Value | |
Total | 0.00 (0.16) | 0.577 | −0.03 (0.18) | <0.001 |
Sex | ||||
Women | −0.01 (0.17) | 0.281 | −0.05 (0.18) | <0.001 |
Men | 0.00 (0.16) | 0.235 | −0.02 (0.18) | <0.001 |
Age group (years) | ||||
<50 | −0.03 (0.17) | 0.004 | −0.06 (0.19) | <0.001 |
50–59 | −0.03 (0.17) | <0.001 | −0.07 (0.17) | <0.001 |
60–69 | 0.03 (0.15) | <0.001 | 0.00 (0.16) | 0.503 |
70–79 | 0.04 (0.16) | <0.001 | 0.01 (0.18) | 0.594 |
≥80 | 0.00 (0.15) | 0.751 | −0.00 (0.19) | 0.791 |
*The predicted equation for EQ-5D health utility was derived from the general population 0.84822−0.00208× (age−50)−0.00002× (age−50)2−0.02090 if women.
†p Value was obtained using one sample t-test.
‡The predicted equation for VAS was 83.183−0.199 (age−50)−0.006 (age−50)2+0.401 if women.
ACS, acute coronary syndromes; EQ-5D, EuroQol five-dimensional questionnaire; PCI, percutaneous coronary intervention; VAS, visual analogue scale.